V. Mazza

Prognostic and Predictive Role of Neutrophil to lymphocyte Ratio in Second Line Immunotherapy of Non-small Cell Lung Cancer

G. Rossi, C. Bennati, S. Tamberi, 2021, International Journal of Clinical Oncology and Cancer Research.

Circulating programmed death ligand-1 (cPD-L1) in non-small-cell lung cancer (NSCLC)

L. Landi, A. D’Incecco, G. Minuti, 2018, Oncotarget.

Benefit of eribulin in a patient with HER2(+) breast cancer who progressed after trastuzumab and lapatinib: a case report.

C. Dazzi, C. Casanova, A. Verlicchi, 2015, Future oncology.

new-molecular-drivers-in-nsclc-the-role-of-met

V. Mazza, 2019, Oncology Research and Reviews.

Treating EGFR mutation resistance in non-small cell lung cancer – role of osimertinib

F. Cappuzzo, V. Mazza, 2017, The application of clinical genetics.

Gemcitabine and paclitaxel combination as second-line chemotherapy in patients with small-cell lung cancer: a phase II study.

C. Dazzi, M. Papi, C. Casanova, 2013, Clinical lung cancer.

Adherence to Mediterranean diet moderates the association between multimorbidity and depressive symptoms in older adults.

F. S. Bersani, M. Cacciafesta, M. Biondi, 2020, Archives of gerontology and geriatrics.